PetMed ExpressPETS
PETS
0
Funds holding %
of 6,780 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
14.23% less ownership
Funds ownership: 60.02% [Q2] → 45.79% (-14.23%) [Q3]
17% less call options, than puts
Call options by funds: $493K | Put options by funds: $597K
20% less funds holding
Funds holding: 115 [Q2] → 92 (-23) [Q3]
31% less capital invested
Capital invested by funds: $50.1M [Q2] → $34.7M (-$15.4M) [Q3]
68% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 34
74% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 53
Research analyst outlook
We haven’t received any recent analyst ratings for PETS.
Financial journalist opinion
Based on 7 articles about PETS published over the past 30 days
Neutral
GlobeNewsWire
5 hours ago
PetMeds® Adopts Limited Duration Shareholder Rights Plan
DELRAY BEACH, Fla., Dec. 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) (“PetMeds” or the “Company”), today announced that its Board of Directors (the “Board”) has adopted a limited duration shareholder rights plan to protect the best interests of all PetMeds shareholders (the “Rights Plan”).
Positive
Zacks Investment Research
2 weeks ago
Here's Why PetMed (PETS) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Neutral
Business Wire
2 weeks ago
PetMeds Migrates to Ordergroove as its New Subscription and Membership Technology Partner
NEW YORK--(BUSINESS WIRE)--Ordergroove, the leading technology platform that powers subscriptions for top brands and retailers, today announced a strategic partnership with PetMed Express, Inc. (NASDAQ: PETS), the original online pet pharmacy dedicated to supporting the health and well-being of four-legged family members. This collaboration marks a significant step in modernizing and scaling PetMeds + PetCareRx's (PETS) subscription and membership capabilities to maximize operational efficiency.
Positive
Seeking Alpha
3 weeks ago
PetMed Express: Why (And Why Not) The Rebound Could Continue
PetMed Express (PETS) surged 35.8% on Nov. 7, following the online pet pharmacy's latest quarterly earnings release. Despite the massive post-earnings surge, further upside may lie ahead, if the turnaround continues. PetMed's management team is implementing a strategy change, not just cost-cutting measures, to continue improving the company's fiscal performance.
Neutral
Seeking Alpha
3 weeks ago
PetMed Express, Inc. (PETS) Q2 2025 Earnings Call Transcript
PetMed Express, Inc. (PETS) Q2 2025 Earnings Call Transcript
Positive
Zacks Investment Research
3 weeks ago
PetMed (PETS) Surpasses Q2 Earnings Estimates
PetMed (PETS) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.06 per share. This compares to break-even earnings per share a year ago.
Neutral
GlobeNewsWire
3 weeks ago
PetMeds® Announces Second Quarter Fiscal 2025 Financial Results
DELRAY BEACH, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its second quarter ended September 30, 2024.
Positive
Zacks Investment Research
1 month ago
4 Retail Stocks to Buy as Further Rate Cuts Loom
Casey's, PetMed, Alibaba and Deckers Outdoor are four retail stocks that should do well in the coming months as the Fed finally initiates rate cuts.
Positive
Zacks Investment Research
1 month ago
Here's Why PetMed (PETS) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Neutral
GlobeNewsWire
2 months ago
PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DELRAY BEACH, Fla., Sept. 27, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS), today announced that on September 27, 2024, PetMeds granted two equity awards previously approved by its Board of Directors to two newly hired executives as a material inducement to employment.
Charts implemented using Lightweight Charts™